S

Spectrum Vascular

Produces vascular-access devices to reduce infections

IT Intern

Winter 2026
No salary listed
Internship
Bachelor's
Warren, NJ, USA
In Person
IT OperationsIT Service Desk & End User Support

About the job

Requirements
  • A bachelor's degree in Information Technology is required.
  • Two or fewer years of experience in a related entry-level Information Technology role is required.
  • The individual must be comfortable communicating with employees at various organizational levels to troubleshoot their Information Technology problems.
Responsibilities
  • Assist with software development by supporting the development and testing of reports in Tableau using data from Snowflake, including coding, debugging, troubleshooting, and deploying code.
  • Provide technical support to users in Warren, New Jersey by troubleshooting and resolving technical issues, gathering requirements with business users, and proposing solutions in coordination with the Head of Information Technology.
  • Provide administrative support for the new headquarters by helping manage network connectivity, printer configuration and setup, access management, and troubleshooting, while coordinating with vendors.
  • Support help desk activities by monitoring tickets related to data uploads and working with business users and subject matter experts to design solutions.
  • Assist with database management activities, including data entry, data backup, and recovery.
  • Document Information Technology processes and procedures to support smooth operations.
  • Participate in training and professional development opportunities to strengthen Information Technology skills and knowledge.
  • Shadow experienced Information Technology professionals to gain a deeper understanding of the field.

About the company

Spectrum Vascular makes vascular access and medication management devices. Its products include central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midlines, arterial lines, and intraosseous needles designed to reduce infections and thrombus formation, with antimicrobial protection features like SV Spectrum and SV BioFlo. The company built its portfolio by acquiring Cook Medical’s vascular access lines in 2023 and AngioDynamics’ PICCs, midlines, and tip-location products in 2024, creating a broad platform for care across settings. Backed by private investors, Spectrum Vascular plans to grow through strategic leadership and expansion, aiming to lower infection risk and complications for patients and caregivers.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

White Plains, New York

Founded

N/A

Get referred to Spectrum Vascular

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • SK Capital’s March 2025 recapitalization funds expansion and accelerates commercial hiring.
  • FDA cleared Spectrum’s Arterial Pressure Monitoring Set/Tray on June 26, 2026.
  • Piccolo’s May 2026 Nav+ Stylet placements create an installed-base story for 2027 sales.

What critics are saying

  • The June 2026 Piccolo acquisition risks integration failure across commercial, regulatory, and manufacturing teams.
  • Hospitals can reject ECGuide adoption if clinicians keep defaulting to chest X-rays in 2027.
  • Becton Dickinson, Teleflex, and ICU Medical can compress margins with broader purchasing contracts.

What makes Spectrum Vascular unique

  • Spectrum Vascular bundled Cook, AngioDynamics, and Piccolo portfolios into one vascular-access platform.
  • Piccolo’s 510(k)-cleared blood-flow sensing guidance eliminates confirmatory chest X-rays.
  • SV Spectrum and SV BioFlo combine antimicrobial and thrombus-reduction features across catheter lines.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Flexible Work Hours
  • Paid Vacation
  • Paid Holidays
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Stock Options
  • Company Equity
  • Wellness Program

Growth & Insights and Company News

6 month growth

24%

1 year growth

21%

2 year growth

21%
PR Newswire
Jun 11th, 2026
Spectrum Vascular acquires Piccolo Medical to advance real-time catheter navigation technology

Spectrum Vascular has acquired Piccolo Medical, a developer of catheter guidance technology, to accelerate commercialisation of next-generation vascular access solutions. Piccolo CEO Augustus Shanahan will join Spectrum alongside his team to advance the company's 510(k)-cleared catheter guidance products. Piccolo's technology uses proprietary blood flow sensing to guide catheter tip placement in real time, eliminating the need for confirmatory chest X-rays. The company completed its first successful patient placements of the Nav+ Stylet in May 2026. Founded in 2016 and based in San Francisco, Piccolo was spun out of the Theranova medical device incubator. Spectrum Vascular, backed by SK Capital Partners, was formed through acquisitions of vascular access businesses from Cook Medical and AngioDynamics.

Cardiac Vascular News
Jun 11th, 2026
Spectrum Vascular acquires Piccolo Medical, accelerating launch of next-generation catheter navigation technology.

Spectrum Vascular acquires Piccolo Medical, accelerating launch of next-generation catheter navigation technology. More in financial: PR News WireThis post was originally published on this site WHITE PLAINS, N.Y., June 11, 2026 /PRNewswire/ - Spectrum Vascular ("Spectrum"), a leading provider of vascular access and medication management products, today announced the acquisition of Piccolo Medical ("Piccolo"), a developer of state-of-the-art catheter guidance products. The transaction deepens a partnership focused on bringing next-generation catheter guidance technology to market and marks a significant step forward in Spectrum's mission to deliver a complete, differentiated vascular access solution to the clinical community. Augustus Shanahan, CEO of Piccolo, will join Spectrum alongside the legacy Piccolo team. The group will advance development and commercialization of its 510(k)-cleared catheter guidance and location products, building upon an innovation roadmap more than a decade in the making. Piccolo's real-time catheter guidance utilizes proprietary blood flow sensing technology to precisely guide catheter tip placement, eliminating the need for confirmatory chest X-rays. Piccolo completed the first successful patient placements of its next-generation Nav+ Stylet in May 2026, marking the beginning of a new era in guided vascular access. "Joining the Spectrum team marks an exciting new chapter for Piccolo and for vascular access as a whole," said Augustus Shanahan. "I am incredibly proud of what the Piccolo team has built over the past decade, and together with Spectrum, we now have the platform, the portfolio, and the reach to set a new standard, delivering better outcomes for patients and real economic value for the hospitals that serve them." Kenneth Miller, CEO of Spectrum, commented, "The acquisition of Piccolo Medical represents an important milestone in our mission to transform vascular access. By combining Piccolo's breakthrough navigation technology with Spectrum's vascular access portfolio and commercial reach, we are uniquely positioned to accelerate innovation, improve patient care, and redefine the standard of care for clinicians worldwide." Together, Piccolo and Spectrum will accelerate commercialization, deepen integration with Spectrum's existing catheter portfolio, and scale the next-generation navigation platform. The combined organization is poised to set a new standard of care in vascular access with greater speed and reach. About Spectrum Vascular Spectrum Vascular, backed by SK Capital Partners, is a leading provider of vascular access and medication management products engineered to reduce healthcare-acquired infections. The Company's mission is to improve the lives of patients worldwide by providing caregivers with high quality, innovative products with exceptional customer service. Innovation has been a core strategic pillar throughout Spectrum's history and many of its products have been designed to deliver antimicrobial protection and thrombus reduction. Spectrum was formed through the acquisition of the vascular access businesses of Cook Medical and AngioDynamics. For more information, please visit www.spectrumvascular.com. About Piccolo Medical Piccolo Medical is a San Francisco-based medical device company and pioneer in catheter navigation and tip confirmation technology. Founded in 2016, Piccolo was spun out of the Theranova medical device incubator and has been funded through private investors as well as prestigious grant awards from The Eunice Kennedy Shriver National Institute of Child Health and Human Development. Piccolo is committed to developing and commercializing innovative vascular access technologies designed to improve clinical outcomes, streamline procedures, and reduce complications for patients. For more information, please visit www.piccolomedical.com. SOURCE Spectrum Vascular

FinSMEs
Mar 31st, 2025
Spectrum Vascular Gains SK Capital Investment

Spectrum Vascular, a NYC-based medical device company, received an undisclosed investment from SK Capital Partners. The funds will be used to expand operations and development efforts. Spectrum Vascular, founded in 2023, specializes in vascular access and medication management products and was formed through the acquisition of the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024.

BioSpace
Jan 13th, 2025
Piccolo Medical, Inc. Announces Distribution Agreement with Spectrum Vascular

SAN FRANCISCO, Jan. 13, 2025 /PRNewswire/ - Piccolo Medical(R), an emerging leader in catheter navigation devices for vascular access procedures, is proud to announce an exclusive distribution agreement with Spectrum Vascular(TM), a leading provider of vascular access and medication management products designed to reduce healthcare acquired infections ("HAI").